AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2014

Feb 26, 2014

30339_dirs_2014-02-26_93ef5c50-54af-4e64-ab1d-36ae56d1addc.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2014-02-24

Reporting Person: Bedwell Warwick (President, Pharma Pkgs Systems)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-02-24	Common Stock	M	9458.0000	$21.2200	Acquired	34816.7600	Direct
2014-02-24	Common Stock	M	8562.0000	$20.4250	Acquired	43378.7600	Direct
2014-02-24	Common Stock	M	6586.0000	$29.5550	Acquired	49964.7600	Direct
2014-02-24	Common Stock	S	8562.0000	$47.5689	Disposed	41402.7600	Direct
2014-02-24	Common Stock	S	16044.0000	$47.4484	Disposed	25358.7600	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-02-24	Stock Option (Right to Buy)	$29.5550	M	6586.0000	Disposed	2023-02-19	Common Stock (6586.0000)	Direct
2014-02-24	Stock Option (Right to Buy)	$21.2200	M	9458.0000	Disposed	2022-02-21	Common Stock (9458.0000)	Direct
2014-02-24	Stock Option (Right to Buy)	$20.4250	M	8562.0000	Disposed	2021-02-22	Common Stock (8562.0000)	Direct
2014-02-24	Stock Option (Right to Buy)	$47.3400	A	14465.0000	Acquired	2024-02-24	Common Stock (14465.0000)	Direct